Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in CKD Patients Receiving Chronic Hemodialysis

ClinicalTrials.gov ID: NCT01503021

Public ClinicalTrials.gov record NCT01503021. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 4, 2026, 4:33 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blinded, Placebo-Controlled, Crossover, Multicenter Phase III Safety Study of Soluble Ferric Pyrophosphate (SFP) in Dialysate in Chronic Kidney Disease Patients Receiving Chronic Hemodialysis

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of the parent study is to assess the short-term safety and tolerability of soluble ferric pyrophosphate (SFP) in dialysate administered to a large number of representative adult chronic kidney disease patients on hemodialysis (CKD-HD). The purpose of the extension study is to assess the long-term safety and tolerability of SFP.

Study identification

NCT ID
NCT01503021
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Enrollment
718 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2011
Primary completion
Dec 31, 2013
Completion
Dec 31, 2013
Last update posted
Oct 24, 2016

2011 – 2014

United States locations

U.S. sites
28
U.S. states
18
U.S. cities
27
Facility City State ZIP Site status
Not listed Mobile Alabama 36688
Not listed Northridge California 91324
Not listed Arvada Colorado 80002
Not listed Westminster Colorado 80031
Not listed Lauderhill Florida 33319
Not listed Marietta Georgia 30060
Not listed Chicago Illinois 60616
Not listed Peoria Illinois 61603
Not listed Columbus Indiana 47201
Not listed Wichita Kansas 67214
Not listed Baton Rouge Louisiana 70808
Not listed Shreveport Louisiana 71101
Not listed Camp Springs Maryland 20748
Not listed Gulfport Mississippi 39501
Not listed McComb Mississippi 39648
Not listed Tupelo Mississippi 38801
Not listed City of Saint Peters Missouri 63376
Not listed Lincoln Nebraska 68510
Not listed Reno Nevada 89511
Not listed Rocky Mount North Carolina 27804
Not listed Dayton Ohio 45428
Not listed Columbia South Carolina 29209
Research Across America Houston Texas 75234
Not listed Houston Texas 77051
Not listed Irving Texas 75061
Not listed Mission Texas 78572
Not listed Temple Texas 76508
Not listed Tyler Texas 75701

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 3 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01503021, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 24, 2016 · Synced Sep 4, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01503021 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →